FDA Brief

Warning letters Drugs

FDA warning letter to

PureRawz

High riskIssued Sep 8, 2025Posted Sep 23, 2025Center for Drug Evaluation and Research (CDER)

FDA warns PureRawz its tianeptine products are unapproved new drugs sold with drug claims.

What happened

In August 2025, FDA reviewed purerawz.co and the company’s Facebook and Instagram accounts and found tianeptine products offered for sale in the U.S. Despite “laboratory and research use only” labeling, FDA says product pages, social media posts, and testimonials showed the products were intended for human use to treat depression, anxiety, and other conditions. FDA says there are no approved applications for these products, making them unapproved new drugs.

What FDA found

  1. The company sold tianeptine products as drugs for human use even though they were labeled for laboratory or research use only.

    FD&C Act §201(g)(1), 21 U.S.C. 321(g)(1); 21 CFR 201.128
  2. The tianeptine products are new drugs without an FDA-approved application, so selling them violates the law.

    FD&C Act §505(a) and §301(d), 21 U.S.C. 355(a) and 331(d)
  3. The products are not generally recognized as safe and effective for the uses described in their labeling.

    FD&C Act §201(p), 21 U.S.C. 321(p)

What FDA wants

Notify FDA in writing within 15 working days of receipt of the specific steps taken to correct the violations and prevent recurrence, with related documentation; if correction is not complete, explain the delay and when it will be finished. Send the response to CDER/OC/Office of Unapproved Drugs and Labeling Compliance at FDAADVISORY@fda.hhs.gov with the firm name and identifier 715218 in the subject line.

Who should pay attention

  • online sellers of research chemicals
  • brands and retailers selling tianeptine
  • quality teams reviewing drug claims on websites and social media

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk